Kestra Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104K Buy
3,132
+293
+10% +$9.7K ﹤0.01% 511
2025
Q1
$95.2K Buy
+2,839
New +$95.2K ﹤0.01% 429